 |
Uduak Grace Thomas is the editor of GenomeWeb's BioInform. She covers bioinformatics, computational biology, and life science informatics. E-mail Uduak Grace Thomas or follow her GenomeWeb Twitter account at @BioInformGW. |
SV Bio Seeks Foothold in NGS-Based Clinical Dx Market with Proprietary Interpretation Pipeline
January 18, 2013
SV Bio Seeks Foothold in NGS-Based Clinical Dx Market with Proprietary Interpretation Pipeline
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Q&A: Foundation Medicine's Eric Neumann on Capturing Knowledge for Clinical Genomics Use
March 1, 2013 / BioInform - New Players, Clinical Applications, and the Lure of Commercialization among 2012 Bioinformatics Trends
January 4, 2013 / BioInform - Silicon Valley Biosystems' Dx Lab Receives CLIA Certification
June 13, 2013 / GenomeWeb Daily News - Knome Teams with Omixon to Provide Whole Genome, Exome HLA Typing
June 4, 2013 / GenomeWeb Daily News - Genomics Experts at ASCO Weigh in on Strategies for TCGA Translation
June 3, 2013 / GenomeWeb Daily News